Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Gene Transfer with AAV9-PHP.B Rescues Hearing in a Mouse Model of Usher Syndrome 3A and Transduces Hair Cells in a Non-human Primate.

György B, Meijer EJ, Ivanchenko MV, Tenneson K, Emond F, Hanlon KS, Indzhykulian AA, Volak A, Karavitaki KD, Tamvakologos PI, Vezina M, Berezovskii VK, Born RT, O'Brien M, Lafond JF, Arsenijevic Y, Kenna MA, Maguire CA, Corey DP.

Mol Ther Methods Clin Dev. 2018 Nov 20;13:1-13. doi: 10.1016/j.omtm.2018.11.003. eCollection 2019 Jun 14.

2.

Safety and efficacy of venoplasty in MS: A randomized, double-blind, sham-controlled phase II trial.

Traboulsee AL, Machan L, Girard JM, Raymond J, Vosoughi R, Hardy BW, Emond F, Gariepy JL, Bone JN, Siskin G, Klass D, Isserow S, Illes J, Sadovnick AD, Li DK.

Neurology. 2018 Oct 30;91(18):e1660-e1668. doi: 10.1212/WNL.0000000000006423. Epub 2018 Sep 28.

3.

Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: perspectives and approaches.

Grand'Maison F, Yeung M, Morrow SA, Lee L, Emond F, Ward BJ, Laneuville P, Schecter R.

Neural Regen Res. 2018 Nov;13(11):1871-1874. doi: 10.4103/1673-5374.239432. Review.

4.

Sequencing of disease-modifying therapies for relapsing-remitting multiple sclerosis: a theoretical approach to optimizing treatment.

Grand'Maison F, Yeung M, Morrow SA, Lee L, Emond F, Ward BJ, Laneuville P, Schecter R.

Curr Med Res Opin. 2018 Aug;34(8):1419-1430. doi: 10.1080/03007995.2018.1458023. Epub 2018 Apr 18.

PMID:
29583054
5.

An ERP study on hostile attribution bias in aggressive and nonaggressive individuals.

Gagnon J, Aubin M, Emond FC, Derguy S, Brochu AF, Bessette M, Jolicoeur P.

Aggress Behav. 2017 May;43(3):217-229. doi: 10.1002/ab.21676. Epub 2016 Sep 14.

PMID:
27629652
6.

Pulvinar sign in a case of anti-HU paraneoplastic encephalitis.

Gamache PL, Gagnon MM, Savard M, Émond F.

Neuroradiol J. 2016 Dec;29(6):436-439. Epub 2016 Aug 24.

7.

Neural mechanisms underlying attribution of hostile intention in nonaggressive individuals: An ERP study.

Gagnon J, Aubin M, Emond FC, Derguy S, Bessette M, Jolicoeur P.

Int J Psychophysiol. 2016 Dec;110:153-162. doi: 10.1016/j.ijpsycho.2016.08.007. Epub 2016 Aug 16.

PMID:
27543324
8.

Changes in the expression of splicing factor transcripts and variations in alternative splicing are associated with lifespan in mice and humans.

Lee BP, Pilling LC, Emond F, Flurkey K, Harrison DE, Yuan R, Peters LL, Kuchel GA, Ferrucci L, Melzer D, Harries LW.

Aging Cell. 2016 Oct;15(5):903-13. doi: 10.1111/acel.12499. Epub 2016 Jun 30.

9.

Attentional focus on subjective interoceptive experience in patients with fibromyalgia.

Borg C, Emond FC, Colson D, Laurent B, Michael GA.

Brain Cogn. 2015 Dec;101:35-43. doi: 10.1016/j.bandc.2015.10.002. Epub 2015 Nov 9.

PMID:
26562055
10.

Towards a bimodal proximity sensor for in situ neurovascular bundle detection during dental implant surgery.

Weber JR, Baribeau F, Grenier P, Emond F, Dubois S, Duchesne F, Girard M, Pope T, Gallant P, Mermut O, Moghadam HG.

Biomed Opt Express. 2013 Dec 2;5(1):16-30. doi: 10.1364/BOE.5.000016. eCollection 2013 Dec 2.

11.

The "reversal sign" following a massive left-hemispheric stroke.

Huot P, Emond F.

Can J Neurol Sci. 2010 May;37(3):395-6. No abstract available.

PMID:
20481276
12.

LRRK2 is not a significant cause of Parkinson's disease in French-Canadians.

Dupré N, Rivière JB, Myers RH, Provencher P, Pourcher E, Emond F, Rouleau GA.

Can J Neurol Sci. 2007 Aug;34(3):333-5.

PMID:
17803032
13.

Microstructured fiber splicing.

Bourliaguet B, Paré C, Emond F, Croteau A, Proulx A, Vallée R.

Opt Express. 2003 Dec 15;11(25):3412-7.

PMID:
19471472
14.

Rotational-angular-momentum relaxation mechanisms in the energy-corrected-sudden scaling theory.

Bonamy L, Emond F.

Phys Rev A. 1995 Feb;51(2):1235-1240. No abstract available.

PMID:
9911704

Supplemental Content

Support Center